1. Scientific Steering Committee `Statement´ section
Posted: 13 July 2007
In its first statement, the SSC considers that the use of NHP will need to be decided on a case-by-case basis, taking into account:
- justification
- the possible existence of alternatives
- ethical considerations
- the problems that could result from not using NHP (i.e. perceived need)
- unnecessary and duplicated or redundant research using nonhuman primates should be avoided at all costs (and for example by a EU-wide coordination between research laboratories),
- that the housing and welfare conditions of the animals should be optimal
- that, for each research proposal, it should be verified that no alternative is available and that it is ethically justified.
However, it considers that for certain experiments there may be no alternatives to the use of non-human primates, for example, drugs and vaccines for diseases such as: AIDS, TSE 1, malaria, influenza.
Click for ADI Response - justification; species differences; limitations of laboratory animal research
Click for ADI Response - alternatives
Click for ADI Response - duplication, redundant research
Click for ADI Response - laboratory animal housing, transport, ethics, primate supply trade